https://www.selleckchem.com/products/h3b-120.html
ac.cn/software/. V.OBJECTIVES Placenta accreta spectrum disorder (PASD) is a rare obstetrical pathology however its incidence is increasing. Morbidity associated with PASD is still high. Even if hysterectomy is considered to be the reference standard treatment, the conservative treatment by leaving the placenta in situ is now an approved option. The objective was to describe management and morbidity of patients with PASD, during the decade, in our French high-level maternity. METHODS It was a retrospective study of management and morbid